权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

High Throughput Biology Core

高通量生物学核心

基本信息

批准号：
10845858
负责人：
Ujjini Havaldar Manjunatha
金额：
$ 59.98万
依托单位：
UNIVERSITY OF TEXAS MED BR GALVESTON
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-05-16 至 2025-04-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10845858
关键词：
Antiviral Agents Archives Area Automation Biochemical Biological Biological Assay Biology Cell Culture System Cells Chemicals Collaborations Coronavirus Data Data Management Resources Dedications Development Disease Dose Enabling Factors Flavivirus Funding Generations Goals Guidelines Henipavirus In Vitro Infrastructure Knowledge Lead Libraries Liquid substance Machine Learning Massachusetts Medical Miniaturization Modeling Molecular Target Pathway interactions Pharmaceutical Chemistry Phenotype Property Proteins Recombinant Proteins Recombinants Replicon Reporter Research Resources Robotics Science Site Specificity Structure-Activity Relationship Switzerland System Testing Texas Universities Validation Viral Viral Proteins Virus Work assay development clinical candidate cytotoxicity data integrity design drug discovery high throughput screening improved instrumentation interest lead candidate lead optimization miniaturize novel pandemic preparedness protein expression response screening small molecule libraries tool vector virology

项目摘要

HIGH-THROUGHPUT BIOLOGY CORE – ABSTRACT The High-Throughput Biology Core will support Project Teams with target-based and phenotypic high-throughput screening (HTS) campaigns to identify diverse tractable chemical matter and SAR (structure-activity relationship)-enabling primary dose-response assays for lead identification and optimization efforts. This will be achieved in close collaboration with the Virology Core (providing molecular target hypothesis and develop BSL2 suitable vectors for translatable in vitro phenotypic assay systems) and the Drug Discovery Core (helping to design tailored screening sets for iterative HTS and providing medicinal chemistry support to enable lead identification and optimization). The High-Throughput Biology Core, with established in-house expertise in assay development and miniaturization, proficiency in diverse recombinant protein expression systems, compound and data management systems, and state-of-the-art screening and automation infrastructure including BSL2 HTS capability, will enable HTS to identify new chemical starting points for drug discovery and also validate new targets. Further, the High-Throughput Biology Core will also enable medicinal chemistry efforts to improve on-target potency and enhance selectivity with robust SAR-enabling primary dose-response assays. This will facilitate the optimization of lead candidates with improved physiochemical properties having desirable potency, selectivity and ADME properties to ultimately deliver safe and efficacious promising clinical candidates. In summary, the High-Throughput Biology Core will enable UNAPP’s drug discovery efforts by helping Project Teams to identify tractable diverse chemical matter necessary to validate new targets and support antiviral drug discovery to ultimately select the best candidate for development.

高通量生物学核心-摘要